Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Israeli wound healing technology company seeks investment for market expansion.

Project region Israel
Industry Biomedicine
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365

CONTACT ADVISOR

  • Simon Laube

    Simon Laube

    Assistant Manager, International Business Advisory

Project highlights exclusive technology - CE certified - entering North America
Project description

The Israeli company develops exclusive wound healing technology products, which promote wound healing by using synthetic negatively charged microspheres ("NCM") to stimulate cells involved in wound healing and tissue regeneration. The company's most advanced wound healing products are classified as IIb medical devices in Europe and are manufactured by factories with European Conformity ("CE") mark certification. The company's products are currently sold in the European Union and some Latin American countries, and it plans to enter the American and Canadian markets. Now the company seeks investment.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive